NasdaqGM - Nasdaq Real Time Price USD

Arcturus Therapeutics Holdings Inc. (ARCT)

11.03 -1.12 (-9.22%)
At close: October 30 at 4:00:01 PM EDT
10.51 -0.52 (-4.67%)
After hours: October 30 at 6:12:53 PM EDT
Trade ARCT on Coinbase
Chart Range Bar
Loading chart for ARCT
  • Previous Close 12.15
  • Open 11.81
  • Bid 4.43 x 200
  • Ask 7.96 x 200
  • Day's Range 10.58 - 11.93
  • 52 Week Range 5.50 - 17.96
  • Volume 1,844,714
  • Avg. Volume 992,007
  • Market Cap (intraday) 313.506M
  • Beta (5Y Monthly) 2.48
  • PE Ratio (TTM) --
  • EPS (TTM) -3.33
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 23.80
  • Zacks Rating Bullish

Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

arcturusrx.com

106

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ARCT
79.93%
S&P 500 (^GSPC)
10.73%

1-Year Return

ARCT
14.54%
S&P 500 (^GSPC)
11.11%

3-Year Return

ARCT
40.89%
S&P 500 (^GSPC)
81.91%

5-Year Return

ARCT
75.46%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.96M
Earnings -23.79M
Profit Margin -803.82%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-20M
-10M
0
10M
-1200.0%
-1000.0%
-800.0%
-600.0%
-400.0%
-200.0%
 

Analyst Insights

View More

Analyst Price Targets

9.00
23.80 Average
11.03 Current
41.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 10/9/2026
Analyst Leerink Partners
Rating Action Maintains
Rating Outperform
Price Action Raises
Price Target 13 -> 19
 

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    312.37M

  • Enterprise Value

    143.82M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    16.46

  • Price/Book (mrq)

    1.82

  • Enterprise Value/Revenue

    7.68

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.96%

  • Return on Equity (ttm)

    -46.31%

  • Revenue (ttm)

    29.37M

  • Net Income Avi to Common (ttm)

    -93.28M

  • Diluted EPS (ttm)

    -3.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    191.48M

  • Total Debt/Equity (mrq)

    13.35%

  • Levered Free Cash Flow (ttm)

    19.26M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

11.03 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 06/17/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 11/29/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 08/13/2021

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch